Ingles Markets, Incorporated
IMKTAConsumer DefensiveNASDAQGrocery Stores · Last scanned Oct 26, 2026
Scan Results
Daily timeframeIngles Markets, Incorporated, together with its subsidiaries, operates a chain of supermarkets in the United States. Valued at $1.67B, IMKTA is a small-cap name in its sector. The company offers food products, such as grocery, meat, and dairy products, produce, frozen food, and other perishables; and non-food products, which include fuel centers, pharmacies, health and beauty care products, and general merchandise, as well as private label items, organic, and locally sourced items.
Market Cap
$1.67B
Beta
0.57
P/E (TTM)
16.07
P/E (Fwd)
18.70
EPS (TTM)
$5.47
EPS (Fwd)
$4.70
ROE
6.3%
ROA
3.4%
Cash
$455.1M
Total Debt
$526.6M
Free CF
$134.6M
52W Change
22.3%
Annual Financials
Cash vs Debt
Where IMKTA stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, IMKTA finished 2.82% below its 150-day moving average ($87.35) and 0.54% below its 200-day moving average ($85.35). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is IMKTA overbought or oversold?
At the October 20, 2026 close, IMKTA's RSI(14) was 50.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $455.1M in cash, though total debt stands at $526.6M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $134.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 6.3%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.4% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $5.68B (2022) to $5.33B (2025).
The relatively low beta of 0.57 suggests IMKTA is a less volatile holding compared to the broader index. No single metric tells the full story. Reviewing IMKTA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.